Assessment of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the fine needle aspirates of metastatic breast carcinomas-Reference-Cited by-同舟云学术

Assessment of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the fine needle aspirates of metastatic breast carcinomas

Published:2011-11-01 Issue:4 Volume:41 Page:308-315
ISSN:8755-1039
Container-title:Diagnostic Cytopathology
language:en
Short-container-title:Diagn. Cytopathol.

Author:

Monaco Sara E.,Wu Yue,Teot Lisa A.,Cai Guoping

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dc.21841/fullpdf

Reference30 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Steroid receptors and their role in the biology and control of breast cancer growth;Cordera;Semin Oncol,2006

3. Selecting endocrine therapy for breast cancer: What role does HER-2/neu status play?;Prowell;Semin Oncol,2006

4. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci USA,2001

5. Estrogen receptors and distinct patterns of breast cancer relapse;Hess;Breast Cancer Res Treat,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in Cancer Detection, Diagnosis, and Prognosis;Sensors;2023-12-20

2. Optimal Assessment of Metastatic Breast Carcinoma: The Value of Cytopathology Combined with Molecular Analysis;Journal of Molecular Pathology;2022-11-22

3. Immunohistochemistry Applied to Breast Cytological Material;Pathobiology;2022

4. Unknown Primary/Undifferentiated Neoplasms;Handbook of Practical Immunohistochemistry;2022

5. Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer;International Journal of Pharmaceutics;2021-08